|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/26 | |
| C07D 257/04 | |||
| C07D 401/06 | |||
| A61K 31/41 | |||
| A61K 31/4439 | |||
| A61P 31/04 |
| (11) | Number of the document | 3119745 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15764743.9 |
| Date of filing the European patent application | 2015-03-19 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/021491 |
| Date | 2015-03-19 |
| (87) | Number | WO 2015/143172 |
| Date | 2015-09-24 |
| (30) | Number | Date | Country code |
| 201461955615 P | 2014-03-19 | US |
| (72) |
HOEKSTRA, William, J., US
YATES, Christopher, M., US
BEHNKE, Mark, US
ALIMARDANOV, Asaf, US
DAVID, Scott, A., US
FRY, Douglas, Franklin, US
|
| (73) |
The U.S.A. as represented by the Secretary, Department of Health and Human Services,
Office of Technology Transfer 6011 Executive Boulevard, Suite 325, Rockville, MD 20852,
US
Mycovia Pharmaceuticals, Inc., 4505 Emperor Boulevard Suite 300, Durham NC 27703, US |
| (54) | ANTIFUNGAL COMPOUND PROCESS |
| ANTIFUNGAL COMPOUND PROCESS |